These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 12471565)

  • 1. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria.
    Denis MB; Davis TM; Hewitt S; Incardona S; Nimol K; Fandeur T; Poravuth Y; Lim C; Socheat D
    Clin Infect Dis; 2002 Dec; 35(12):1469-76. PubMed ID: 12471565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria.
    Karunajeewa H; Lim C; Hung TY; Ilett KF; Denis MB; Socheat D; Davis TM
    Br J Clin Pharmacol; 2004 Jan; 57(1):93-9. PubMed ID: 14678346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized open study to assess the efficacy and tolerability of dihydroartemisinin-piperaquine for the treatment of uncomplicated falciparum malaria in Cambodia.
    Janssens B; van Herp M; Goubert L; Chan S; Uong S; Nong S; Socheat D; Brockman A; Ashley EA; Van Damme W
    Trop Med Int Health; 2007 Feb; 12(2):251-9. PubMed ID: 17300633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial.
    Tran TH; Dolecek C; Pham PM; Nguyen TD; Nguyen TT; Le HT; Dong TH; Tran TT; Stepniewska K; White NJ; Farrar J
    Lancet; 2004 Jan; 363(9402):18-22. PubMed ID: 14723988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
    Ashley EA; Krudsood S; Phaiphun L; Srivilairit S; McGready R; Leowattana W; Hutagalung R; Wilairatana P; Brockman A; Looareesuwan S; Nosten F; White NJ
    J Infect Dis; 2004 Nov; 190(10):1773-82. PubMed ID: 15499533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
    Karema C; Fanello CI; van Overmeir C; van Geertruyden JP; van Doren W; Ngamije D; D'Alessandro U
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1105-11. PubMed ID: 16766006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
    Tangpukdee N; Krudsood S; Thanachartwet W; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Wilairatana P; Phongtananant S; Kano S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1085-91. PubMed ID: 16438129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.
    Leang R; Taylor WR; Bouth DM; Song L; Tarning J; Char MC; Kim S; Witkowski B; Duru V; Domergue A; Khim N; Ringwald P; Menard D
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4719-26. PubMed ID: 26014949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010.
    Leang R; Barrette A; Bouth DM; Menard D; Abdur R; Duong S; Ringwald P
    Antimicrob Agents Chemother; 2013 Feb; 57(2):818-26. PubMed ID: 23208711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children.
    Yeka A; Wallender E; Mulebeke R; Kibuuka A; Kigozi R; Bosco A; Kyambadde P; Opigo J; Kalyesubula S; Senzoga J; Vinden J; Conrad M; Rosenthal PJ
    J Infect Dis; 2019 Mar; 219(7):1112-1120. PubMed ID: 30418593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and ex vivo pharmacodynamic antimalarial activity of dihydroartemisinin-piperaquine in patients with uncomplicated falciparum malaria in Vietnam.
    Nguyen DV; Nguyen QP; Nguyen ND; Le TT; Nguyen TD; Dinh DN; Nguyen TX; Bui D; Chavchich M; Edstein MD
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3534-7. PubMed ID: 19528277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos).
    Mayxay M; Thongpraseuth V; Khanthavong M; Lindegårdh N; Barends M; Keola S; Pongvongsa T; Phompida S; Phetsouvanh R; Stepniewska K; White NJ; Newton PN
    Trop Med Int Health; 2006 Aug; 11(8):1157-65. PubMed ID: 16903879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of dihydroartemisinin-piperaquine.
    Myint HY; Ashley EA; Day NP; Nosten F; White NJ
    Trans R Soc Trop Med Hyg; 2007 Sep; 101(9):858-66. PubMed ID: 17659311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, controlled trial of artemisinin-piperaquine vs dihydroartemisinin-piperaquine phosphate in treatment of falciparum malaria.
    Trung TN; Tan B; Van Phuc D; Song JP
    Chin J Integr Med; 2009 Jun; 15(3):189-92. PubMed ID: 19568711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.
    Manning J; Vanachayangkul P; Lon C; Spring M; So M; Sea D; Se Y; Somethy S; Phann ST; Chann S; Sriwichai S; Buathong N; Kuntawunginn W; Mitprasat M; Siripokasupkul R; Teja-Isavadharm P; Soh E; Timmermans A; Lanteri C; Kaewkungwal J; Auayporn M; Tang D; Chour CM; Prom S; Haigney M; Cantilena L; Saunders D
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6056-67. PubMed ID: 25092702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic efficacy and safety of compound dihydroartemisinin/piperaquine for uncomplicated Plasmodium falciparum infection in Laiza City of Myanmar bordering on China].
    Sun XD; Zhang ZX; Wang J; Deng Y; Yang YC; Lasi JH; Sun XY; Wang H
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2011 Oct; 29(5):372-5. PubMed ID: 24830201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized comparison of amodiaquine plus sulfadoxine-pyrimethamine, artemether-lumefantrine, and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in Burkina Faso.
    Zongo I; Dorsey G; Rouamba N; Dokomajilar C; Séré Y; Rosenthal PJ; Ouédraogo JB
    Clin Infect Dis; 2007 Dec; 45(11):1453-61. PubMed ID: 17990228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.